QMR Therapy For Osteoarthritis Developed Part I

Osteoarthritis is the most common form of arthritis or joint disease and is one of the primary causes of pain and disability in advancing years of life. Osteo arthritis usually affects people over the age of 50. Some degree of osteoarthritis will develop in everyone in old age and is estimated that three out of four persons who are more than 60 years of age will have definite evidence of osteoarthritis in at least one joint.

Some 15-30% who suffer from osteoarthritis over the age of 40 need medical attention. Knee replacement surgery was the only treatment available. It is a well known fact that surgery has its own side effects and also requires prolonged hospitalisation.

Quantum Magnetic Resonance Therapy (QMR TherapyTM) method is painless, safe, non-invasive and cost effective alternative method of treatment when compared to surgery.

What is this treatment?

QMR TherapyTM is the world"s first scientifically proven, non-surgical treatment to help regenerate cartilage and restore mobility of arthritic knee joints.

Safety of QMR Therapy^TM

QMR TherapyTM is non-invasive, painless and safe. Clinical trials have been conducted on over 400 cases of osteoarthritis. The findings were published in the Journal of Aerospace Medicine. It involves the application of electromagnetic beams to regenerate tissues that wear and tear due to ageing. The beams can be precisely controlled and focused onto tissues therein generating streaming voltage potentials. This is lower than what is used in cell phones thereby making it safe for human use. The International Commission for Non-Ionizing Radiation Protection (ICNIRP) has defined emission levels that are considered safe for human use. Both electric and magnetic field emissions from QMR TherapyTM exposure are well below the levels specified by ICNIRP. These levels were certified by the LRDE, Electronics and Radar Development Establishment, a government of India body attached to the DRDO. (Defence Research and Development Organisation)

Clinical trials led by Wg. Cdr (Dr.) VG Vasishta began in 2004 at the Institute of Aerospace Medicine, an Indian Air Force establishment. These clinical trials were approved by the Ethics Committee of the Institute under the aegis of the Indian Council of Medical Research. Phase 1 and 2 trials on osteoarthritis ended in 2006. The study was conducted using the internationally accepted American Knee Society rating system Vasishta VG et al, Rotational Field Magnetic Resonance (RFQMR) in treatment of osteoarthritis of the knee joint, Indian Journal of Aerospace Medicine, 48 (2), 2004; 1-7